Featured Research

from universities, journals, and other organizations

Inflammation Marker Predicts Colon Cancer

Date:
February 5, 2004
Source:
Johns Hopkins Medical Institutions
Summary:
C-reactive protein (CRP) -- a marker of inflammation circulating in the blood already associated with increased risk of heart disease -- can also be used to identify a person's risk of developing colon cancer, according to a Johns Hopkins study.

C-reactive protein (CRP) -- a marker of inflammation circulating in the blood already associated with increased risk of heart disease -- can also be used to identify a person's risk of developing colon cancer, according to a Johns Hopkins study.

Related Articles


Results of the study, published in the Feb. 4 issue of The Journal of the American Medical Association, showed that over an 11-year period, people with higher levels of CRP in their blood (a median of 2.44 milligrams per liter) were more likely to develop colorectal cancers than those with low levels of CRP (a median of 1.94 mg/L).

"Higher levels of C-reactive protein are linked to an increased risk of several apparently distinct, chronic diseases: heart disease, stroke, diabetes, and now colon cancer," says Thomas "Tate" P. Erlinger, M.D., M.P.H., lead author of the study and an assistant professor of medicine at Hopkins. "However, it's not clear yet how or whether measuring C-reactive protein would fit into current screening and prevention strategies for colorectal cancer. Further studies should help answer these questions and help clarify the mechanism by which inflammation increases the risk of cancer."

Erlinger and colleagues studied the records of 22,887 adults who participated in the CLUE II study, conducted in Washington County, Md., looking to identify those who developed colon or rectal cancer. In the CLUE II investigation, named for its campaign, "Give Us A Clue to Cancer and Heart Disease" and started between May and October 1989, study volunteers provided a blood sample and completed a brief health questionnaire. They since have been followed by additional questionnaires and tracking data.

Comparing the CLUE II medical records with the Washington County and Maryland State cancer registries, the Hopkins team noted 172 people who were diagnosed with either colon or rectal cancer following their initial date of blood draw through December 2000. Of these, 131 had colon cancer and 41 had rectal cancer. Researchers then compared the health records of each of these individuals with those of up to two healthy volunteers who joined the study at the same time, using the healthy volunteers as a control group.

Median CRP levels at baseline were higher among people who subsequently developed colon cancer (2.69 mg/L) than among those who remained free of disease (1.97 mg/L). By contrast, CRP concentrations were not significantly different between cases of rectal cancer (1.79 mg/L) and the controls (1.81 mg/L).

The study also found that:

* The odds of developing colorectal cancers increased progressively with higher concentrations of CRP. Overall, people in the highest fourth of CRP had twice the risk of developing colorectal cancer, and 2.5 times the risk of developing colon cancer, as those in the lowest fourth.

* Among nonsmokers, those in the highest fourth of CRP were 2.5 times as likely to develop colorectal cancer, and 3.5 times as likely to develop colon cancer, as those in the lowest fourth.

* Those who had taken either aspirin or nonsteroidal anti-inflammatory agents within the 48 hours prior to blood draw had a reduced risk of colorectal cancer.

* The association of inflammation with colon cancer was unrelated to diabetes, going against the belief that diabetes acts as the mediator between inflammation and cancer risk.

Erlinger notes that while these results should apply to the general population, most of the study population was Caucasian, so further studies should look at a more diverse group.

The study was supported by grants from the Maryland Cigarette Restitution Fund, the National Institutes of Health, and the American Institute for Cancer Research. Co-authors were Elizabeth A. Platz and Kathy J. Helzlsouer of Hopkins and Nader Rifai of Harvard Medical School.


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Inflammation Marker Predicts Colon Cancer." ScienceDaily. ScienceDaily, 5 February 2004. <www.sciencedaily.com/releases/2004/02/040204000024.htm>.
Johns Hopkins Medical Institutions. (2004, February 5). Inflammation Marker Predicts Colon Cancer. ScienceDaily. Retrieved April 2, 2015 from www.sciencedaily.com/releases/2004/02/040204000024.htm
Johns Hopkins Medical Institutions. "Inflammation Marker Predicts Colon Cancer." ScienceDaily. www.sciencedaily.com/releases/2004/02/040204000024.htm (accessed April 2, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, April 2, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Wound-Healing Laser Soon to Be a Reality Israeli Scientist

Wound-Healing Laser Soon to Be a Reality Israeli Scientist

Reuters - Innovations Video Online (Apr. 1, 2015) Israeli scientists says laser bonding of tissue allows much faster healing and less scarring. Amy Pollock has more. Video provided by Reuters
Powered by NewsLook.com
Liberia Sees Resurgence of Drug Trafficking as Ebola Wanes

Liberia Sees Resurgence of Drug Trafficking as Ebola Wanes

AFP (Apr. 1, 2015) The governments of Liberia and Sierra Leone have been busy fighting the menace created by the deadly Ebola virus, but illicit drug lords have taken advantage of the situation to advance the drug trade. Duration: 01:12 Video provided by AFP
Powered by NewsLook.com
Stigma Stalks India's Leprosy Sufferers as Disease Returns

Stigma Stalks India's Leprosy Sufferers as Disease Returns

AFP (Apr. 1, 2015) The Indian government declared victory over leprosy in 2005, but the disease is making a comeback in some parts of the country, with more than a hundred thousand lepers still living in colonies, shunned from society. Duration: 02:41 Video provided by AFP
Powered by NewsLook.com
7-Year-Old Girl Gets 3-D Printed 'robohand'

7-Year-Old Girl Gets 3-D Printed 'robohand'

AP (Mar. 31, 2015) Although she never had much interest in prosthetic limbs before, Faith Lennox couldn&apos;t wait to slip on her new robohand. The 7-year-old, who lost part of her left arm when she was a baby, grabbed it as soon as it came off a 3-D printer. (March 31) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins